1. Home
  2. NSSC vs VCEL Comparison

NSSC vs VCEL Comparison

Compare NSSC & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NAPCO Security Technologies Inc.

NSSC

NAPCO Security Technologies Inc.

HOLD

Current Price

$37.33

Market Cap

1.6B

ML Signal

HOLD

Logo Vericel Corporation

VCEL

Vericel Corporation

HOLD

Current Price

$34.76

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NSSC
VCEL
Founded
1969
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.7B
IPO Year
1994
1996

Fundamental Metrics

Financial Performance
Metric
NSSC
VCEL
Price
$37.33
$34.76
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
5
Target Price
$48.17
$57.75
AVG Volume (30 Days)
364.5K
589.6K
Earning Date
05-04-2026
05-07-2026
Dividend Yield
1.33%
N/A
EPS Growth
N/A
60.00
EPS
0.70
N/A
Revenue
$181,621,000.00
$276,259,000.00
Revenue This Year
$13.63
$19.40
Revenue Next Year
$10.05
$18.24
P/E Ratio
$52.59
N/A
Revenue Growth
N/A
16.45
52 Week Low
$26.44
$28.95
52 Week High
$47.61
$45.97

Technical Indicators

Market Signals
Indicator
NSSC
VCEL
Relative Strength Index (RSI) 37.20 52.98
Support Level $29.88 $33.91
Resistance Level $44.43 $38.31
Average True Range (ATR) 1.48 1.87
MACD -0.38 0.07
Stochastic Oscillator 28.28 35.26

Price Performance

Historical Comparison
NSSC
VCEL

About NSSC NAPCO Security Technologies Inc.

NAPCO Security Technologies Inc manufactures security products, encompassing access control systems, door-locking products, intrusion and fire alarm systems and video surveillance products. Its products are used for various applications which includes alarm systems like automatic communicators, combination control panels/digital communicators and digital keypad systems, fire alarm control panel and area detectors mainly used for commercial, residential, institutional, industrial and governmental uses. Geographically, the company derives a majority of its revenue from the United States.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: